Rare diseases
Investigational molecules
Locations
A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis
PolandA study comparing under-the-skin and into-the-vein alpha1-proteinase inhibitor treatment in patients with alpha1-antitrypsin deficiency
PolandA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
PolandA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
PolandStudy of STK-012 Alone and Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
PolandTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
PolandStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
PolandA study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia
PolandA Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
PolandStudy comparing datopotamab deruxtecan with or without durvalumab to chemotherapy with pembrolizumab for patients with triple-negative breast cancer
PolandA study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma
PolandA study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
